删除或更新信息,请邮件至freekaoyan#163.com(#换成@)

连氨基脲链的三氮唑并噻二唑类DOT1L抑制剂的设计、合成及活性

本站小编 Free考研考试/2022-02-14

鐎殿喒鍋撻梺顐g濠€鎵博濮楃P闁挎稒鐭粩瀛樼▔閸モ晩娼氶柤鏉垮暟閻栫儤绋夐幘鑼懝閻犲洦宕橀~瀣紣閹达附顓瑰〒姘虫硶濠€鍛存晬鐏炲墽妲ㄩ柡鍫厸缁楀宕氭0浣侯伇闁告帒妫濋幐鍫曟晬娴h櫣鍗滈悗鐢垫嚀閸ㄦ繄绮诲Δ瀣<
547闁圭鍋撻梻鍕╁灪閻楀酣鎳撻崘顏嗗煛闁兼澘鍟畷锟�1130缂佸绉电€垫氨鈧纰嶉弳鈧柡澶嬪姉濞堟垿宕¢崘褏绋囩紒澶婄Ч閸樸倖绺藉Δ鍜佹毌閹煎瓨鎸堕埀顑挎祰椤锛愰幋顖滅婵炴垹鏁稿ú濠囨嚐鏉堫偒鍤旈柕鍡曡兌缁€趁规惔娑掑亾娴g晫妲堥柛鎺撴偠閳ь兛绶氶崳楣冩懚瀹ュ啠鍋撴担鐑樺€炵€规悶鍎埀顑胯兌椤撴悂鎮堕崱鎰ㄥ亾娴f亽浠﹀ù鍏煎搸閳ь兛娴囬崒銊﹀濮樸儮鍋撴担瑙勬畬闁煎弶褰冪缓楣冩偠閸℃劏鍋撴担鐤幀闁哄倸娲㈤埀顑挎祰婢规捇寮甸妯峰亾娴h鐓€闂傚倽顔婄槐鍫曞箻椤撴壕鍋撴担鍦€婇悗娑宠礋閳ь兛绀佺亸鎵偓娑宠礋閳ь兛娴囬鍝ョ不濡や焦绨氶柕鍡曠瀹稿宕g仦鍌楀亾娴e憡鍕鹃柣鐐叉閳ь兛鐒﹂弬鍌氣柦濮瑰洠鍋撴担鍛婃噸閻庢冻璐熼埀顑挎缂嶅鎳栭懠顒冾潶缂佹冻鎷�28缂侇偉顕ч鐔虹矓閹搭垳纾�

摘要/Abstract



依据优势片段结合的药物设计方法,设计了新的连接有氨基脲链的三氮唑并噻二唑类DOT1L(类端粒沉默干扰体1)酶抑制剂.化合物的合成以芳香酸为原料,经五步反应得到了含苄基氯结构的三氮唑并噻二唑中间体13.弱碱性(DIPEA)条件下,化合物13与氨基侧链发生亲核取代反应,得到连氨基脲链的三氮唑并噻二唑类化合物15a~15k;而在强碱性(NaH)条件下,化合物13自身反应得到新的三氮唑并噻二唑连三氮唑并噻二嗪的二聚结构类似物22a~22d.测试了化合物1522对DOT1L的酶抑制活性,结果显示所测化合物在50 μmol·L-1时表现出中等或较弱的DOT1L抑制活性,其中化合物15k和二聚类似物22a活性最好,IC50值分别为25.92和10.59μmol·L-1,但均低于阳性对照物(E)-6-(2-(呋喃-2-基)乙烯基)-3-苯基-[1,2,4]三唑[3,4-b][1,3,4]噻二唑的酶抑制活性.分子对接实验提示,氨基脲侧链体积较大,可能是所合成化合物活性较低的主要原因.
关键词: DOT1L抑制剂, 三氮唑并噻二唑, 三氮唑并噻二嗪, 亲核取代
Based on the drug design method of combination of privileged fragments, a series of novel triazolothiadiazole derivatives linked with amino side chain containing urea group were designed as potential DOT1L (disruptor of telomeric silencing 1-like) inhibitors. The intermediate 13 with benzyl chloride on triazolothiadiazole structure was synthesized from aromatic acid through five steps. Under the condition of weak base (DIPEA), the nucleophilic substitution reaction between 13 and amino chain with urea group resulted in triazolothiadiazole derivatives linked with amino side chain containing urea group 15a~15k, while under the condition of strong base (NaH), the new dimeric structure analogues 22a~22d bearing with triazolothiadiazole-triazolothiadiazine were obtained by intermolecular reaction of two molecules of 13. The inhibitory activities of compounds 15 and 22 against DOT1L were tested. The results showed that the tested compounds exhibited moderate or weak DOT1L inhibitory activities at 50 μmol·L-1. Among them, compounds 15k and 22a were the best ones with IC50 values of 25.92 and 10.59 μmol·L-1, respectively, lower than that of the positive control (E)-6-(2-(furan-2-yl)vinyl)-3-phenyl-[1,2, 4]triazolo[3,4-b] [1,3,4]thiadiazole (10). The results of docking experiments suggested that the bulky amino-urea side chain might be the main reason for the loss of the activities of the compounds, which sterically hindered the molecular from binding to the DOT1L enzyme.
Key words: DOT1L inhibitor, triazolothiadiazole, triazolothiadiazine, nucleophilic substitution


PDF全文下载地址:

点我下载PDF
闁绘劗鎳撻崵顔剧博鐎n亜绁柟鍏肩矌閸岋拷2濞戞挸娲ㄩ~鎺楁嚀閸愵亞鍩¢柣銏ゆ涧閻℃瑩鎮ч崼锝囥偒闁哄倹鐟辩槐锟�
濠㈠爢鍥у姤闁告帒妫涢銏ゆ鐎n喖鍘撮柡鍕靛灣椤戝洦绋夐埀顒€鈻庨檱閳ь剙鍟伴悥娲晬鐏炵瓔鍤犲ù婊冮椤┭勬媴閺囩喓鍙€闁归潧褰炵粭鎾寸▔濮樻剚鍤﹂柟绋挎搐閻i箖寮▎鎰稄闁挎稑鏈崹銊ф媼閸涘﹥绠掔€垫澘鐗嗛ˇ鍧楁偪閹达附锛栭柕鍡曞ree濠㈠綊鈧稒銆冮柛鎺戞椤掔喐绋婇悩鐢电Ч闁兼澘鍟伴悥鍝勄庢潏顐熷亾閺囨氨鐟╁☉鎾翠亢椤曡櫕娼忛崨顓у殼20妤犵偠鎻槐婵嬪箑閼姐倗娉㈠ù婊冩缁夊鈧湱鍋熼弫銈夋儍閸曨剙鐦归悗瑙勭閺嗏偓闁哄鍔栭悡锛勬嫚閵忊剝鐓欐繛澶嬫礀瀵攱寰勫鍕槑闁哄倽顫夌涵鍫曟晬鐏炵偓绠掗梻鍥e亾閻熸洑鑳跺▓鎴︽儑鐎n厾绠栭柡澶涙嫹
相关话题/设计 结构 干扰 药物 实验